reports
Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sc...
Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that Rick Stewart, Chief Executive Officer of Achieve, will be presenting today at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025, at 10:00 a.m. EST. ...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 11 February 2025
The Bulgarian market settled the first day of the week mixed as the negative bias came from light-volume trades with recent top gainers, like M+S Hydraulic (MSH, BGN 8.80, -6.88%), Synergon (SNRG, 0.985, -4.37%) and Korado (KBG, BGN 4.14, -5.91%). The advancer-decliner line was in balance within SOFIX (896.11, +0.20%) and settled slightly above previous close led by Sopharma (SFA, BGN 5.78, +1.40%) and Bulgarian Real Estate (BREF, BGN 4.22, +1.93%). The block trades with Synthetica (SYN, BGN 72....
Achieve Life Sciences Announces Positive Outcome of Second Data Safety...
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2 2025 SEATTLE and VANCOUVER, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that the Data Saf...
- Martin Dimitrov
- Veselin Radoychev Please Change Surname
Weekly bulletin - 27 January - 31 January 2025
The Bulgarian stock market managed to end the week slightly higher on Friday, while global markets continued with the volatile performance. The local Benchmark SOFIX added 0.5% to settle at 892.36, as all the other major indexes closed up, ranging from 0.1% to 0.7%. The shares of three companies- SOFIX members were the top gainers within our list of selected names – Sirma Group Holding (SGH, BGN 1.00, +6.4%), Bulgarian Real Estate Fund (BREF, BGN 4.08, +4.1%) and Central Cooperative Bank (CCB,...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 31 January 2025
There was some increased activity under the surface on a broad range of sectors, though the main indexes settled near previous session’s levels. Sirma Group (SGH, BGN 0.97, +2.11%) led the gainers and together with increased value of the real estate sector, settled SOFIX (891.87, +0.33%) and BGREIT (213.56, +0.11%) with gains. The widened Bid/Ask spreads accelerated the negative effect of the light-volume trades with Smart Organic (SO, BGN 23.40, -4.88%) and Stara Planina (SPH, BGN 8.65, -3.89%)...
Weekly bulletin - 20 January - 24 January 2025
All indexes on the BSE retraced during the last week with the blue-chip SOFIX falling the least (887.56, -0.3%), while the broader BGTR30 dropped the most (854.80, -0.8%). The gainers within out watchlist were led by Doverie United Holding (DUH, BGN 8.06, +3.3%), which rose on the news of record profits of its subsidiary Moldindconbank. On the other hand, Wiser Technology (WISR, BGN 4.80, -5.9%) and Neochim (NEOH, BGN 27.20, -4.2%) dropped the most. Both the volumes (+114.2% YtD average) and the...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 24 January 2025
Thursday’s session run under mixed actions, yet the calculations led to slight dip for the major index in range between -0.11% to -0.08%, while BGREIT (213.76) alone gained 0.44% supported by the real estate sector, represented by Bulgarian Real Estate Fund (BREF, BGN 3.92, +1.55%) and Advance Terrafund (ATER, BGN 3.25, +0.62%). Elana Agrocredit (EAC, BGN 1.07, -2.73%) led the losers within the SOFIX (891.80, -0.08%) while Synergon (SNRG, BGN 1.03, -6.36%) weighed on BGBX40 (171.63, -0.08%). The...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 21 January 2025
A positive reaction to the latest financial data from the Moldavian Bank, the main subsidiary of Doverie (DUH, BGN 8.18, +4.87%) and increased buying interest in First Investment Bank (FIB, BGN 4.32, +1.89%) were the engine of this otherwise quiet first session of the week. The major indexes settled mixed as SOFIX (892.69) advanced by 0.27%, while BGBX40 (171.84, +0.08%) and BGTR30 (861.31, -0.05%) remained almost unchanged as the negative bias from Texim Bank (TXIM, BGN 3.60, -2.70%) and Sophar...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 16 January 2025
The Bulgarian market had a volatile session on Wednesday, but finally the major indexes settled with small deviations from the previous close. The advancers and decliners were in balance within the SOFIX (891.23, -0.08%) as the Central Cooperative Bank (CCB, BGN 1.68, -2.33%) weighed the most on the benchmark. M+S Hydraulic (MSH, BGN 9.30, -2.11%), Neochim (NEOH, BGN 27.20, -2.16%) and Zarneni Hrani (ZHBG, BGN 0.13, -2.26%) added a negative spice to broad indexes. Despite the light-volume choppy...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Bulgaria Outlook 2025
OUTLOOK 2025 – 6 VALUE STOCKS FOR YOUR PORTFOLIO Bulgaria's economy showed resilience despite the world and domestic challenges. In the first three quarters of 2024, the country posted steady annual GDP growth of 1.9% in Q1, 2.3% in Q2 and 2.6% in Q3 (non-seasonally adjusted data). The main drivers behind the growth were the individual and government consumption, which accelerated their contribution throughout the three quarters. Inflation has been on a downward trend, aligning with global ...
Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to ...
Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors New Directors Bring Extensive Leadership Experience in Corporate Strategy and Commercialization SEATTLE and VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that Kristen Slaoui, Ph.D., and Nancy Phelan will join its Board of Directors. Achieve also announced that curren...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 8 January 2025
The Bulgarian market weakened and only few outstanding names like Shelly Group (SLYG, EUR 34.00, -2.58%), the freshly renamed Wiser Technology (WISR, BGN 5.00, -4.76%) and Doverie (DUH, BGN 7.70, -1.28%) concentrated the investors’ focus and provided significant liquidity to the market. The negative bias was reinforced by low-volume price actions with Agria (AGH, BGN 19.50, -3.47%) and First Investment Bank (FIB, BGN 4.20, -2.33%) on poor buy order side within the benchmark, while BG Agro (BGAG,...
Achieve Life Sciences Announces Critical Milestone Successfully Reache...
Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement for NDA Submission ORCA-OL Long-Term Exposure Timelines Remain on Track with No Safety Concerns Identified Planned Cytisinicline NDA Submission on Target for Q2 2025 SEATTLE and VANCOUVER, British Columbia, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a lat...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Weekly bulletin - 30 December 2024 - 3 January 2025
The Bulgarian stocks marked a mixed start of the year, as during the two trading days, local benchmark SOFIX lost 0.4% to settle at 889.27. The broader BGBX40 (171.79, +0.0%) and BGTR30 (865.04, +0.2%) kept to a tighter range. The weekly top performer within our selected companies were Industrial Capital Holding (HIKA, BGN 2.68, +5.5%) and Alcomet (ALCM, BGN 6.75, +5.5%), while two of the SOFIX members – Eurohold Bulgaria (EUBG, BGN 1.92, -3,5%) and Doverie United Holding (DUH, BGN 7,80, -2,0%)...
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthca...
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week SEATTLE and VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company focused on the development and commercialization of cytisinicline for nicotine dependence, announced today that the company will be hosting in-person one-on-one meetings coinciding with the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, January 13-16, 2025. Rick Stewart, Chief Executive Officer of Achieve, along with other members ...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 3 January 2025
The Bulgarian equity market experienced some volatility on the first session of the year. The major indexes initially moved lower, pressed by poor trading activity in names related with some rebalancing at the end of the year, like Elana Agrocredit (EAC, BGN 1.08, -2.70%) and Eurohold (EUBG, BGN 1.92, -3.52%), but finally with the positive price actions in the tech sector – Shelly (SLYG, EUR 34.90, +3.87%) and Sirma (SGH, BGN 0.965, +2.12%) and the significant support from Alcomet (ALCM, BGN 7.0...
- Research Team
WOOD Flash – Alkaloid AD Skopje/ Hellenic Bank/ ONE United Properties/...
We discontinue our coverage of the following stocks, with immediate effect: Alkaloid AD Skopje Hellenic Bank ONE United Properties Photon Energy Sirma Group Holding Sopharma AD Telecom Egypt We caution against using the forecasts, ratings and price target guidance issued previously on these stocks.
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 20 December 2024
The Bulgarian market had another strong showing on Thursday, where SOFIX (879.19) recorded new 16-years high with 1.94% gain. The sharp positive actions of Eurohold (EUBG, BGN 1.85, +9.47%) and First Investment Bank (FIB, BGN 4.06, +4.10%) reflected less on the broad indexes, BGBX40 (170.33, +1.22%) and BGTR30 (856.82, +0.61%), while the real estate sector underperformed and BGREIT (214.21) declined by 0.22%. The volumes improved compared to previous days mainly on block trades with Bulgarian St...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Weekly bulletin - 2 December - 6 December 2024
The Bulgarian stock market ended the week with no clear direction, as the local benchmark SOFIX added 0.1% to settle at 847.67. The broader BGBX40 (166.63, +0.3%) and BGTR30 (846.93, -0.4%) performed in different directions, while the sector BGREIT (213.60,+0.6 %) gained the most, supported by the strong movement of Sopharma Buildings (SFB, BGN 16.50, +19.57%). The weekly top performer within our selected companies was Trace Group Hold (T57, BGN 6.0,+6.2%), followed by Telematic Interactive Bul...
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer SEATTLE and VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for the treatment of nicotine dependence, today announced that Mark Oki has joined the company as its Chief Financial Officer, effective December 5, 2024. Mr. Oki will oversee the company's financial strategy and operations, including accounting, investor relations, information technology, legal a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.